Kestra Medical Technologies (KMTS) Revenue & Revenue Breakdown
Kestra Medical Technologies Revenue Highlights
Latest Revenue (Y)
$27.81M
Latest Revenue (Q)
$17.23M
Kestra Medical Technologies Revenue by Period
Kestra Medical Technologies Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-04-30 | $27.81M | 264.53% |
| 2023-04-30 | $7.63M | 100.00% |
| 2021-04-30 | - | 100.00% |
| 2020-04-30 | - | - |
Kestra Medical Technologies generated $27.81M in revenue during NA 2023, up 264.53% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Kestra Medical Technologies Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-04-30 | $17.23M | 14.20% |
| 2025-01-31 | $15.09M | 50.09% |
| 2024-04-30 | $10.05M | 21.47% |
| 2024-01-31 | $8.28M | 100.00% |
| 2021-07-31 | - | 100.00% |
| 2020-07-31 | - | - |
Kestra Medical Technologies generated $17.23M in revenue during Q4 2024, up 14.20% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Kestra Medical Technologies Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NEOG | Neogen | $894.66M | $209.19M |
| EVO | Evotec SE | $781.43M | $208.73M |
| AZTA | Azenta | $656.32M | $143.94M |
| NVCR | NovoCure | $605.22M | $167.20M |
| WVE | Wave Life Sciences | $108.30M | $7.61M |
| BLFS | BioLife Solutions | $82.25M | $25.42M |
| KMTS | KESTRA MEDICAL | $27.81M | $17.23M |
| PGEN | Precigen | $3.92M | $856.00K |
| STAA | STAAR Surgical | $313.90K | $44.32B |
| PLSE | Pulse Biosciences | - | - |
| TERN | Terns Pharmaceuticals | - | - |